Potent and specific aminopeptidase A (APA, glutamylaminopeptidase, EC 3.4.1
1.7) inhibitors could be useful as powerful tools in the study of the physi
ological involvement of this enzyme in the metabolism of various peptides.
Thus, using newly designed selective APA inhibitors, APA has been shown to
participate in the metabolism of cholecystokinin and to be responsible for
the conversion of angiotensin II (Ang II), a peripheral vasoconstrictor pep
tide, into Ang III, which has been recently shown to induce an increase in
blood pressure and in vasopressin release in rat brain. Moreover, APA was s
hown to be overexpressed in several types of malignant tumours, probably by
inducing the formation of as yet unidentified cell proliferating active pe
ptide(s). This review highlights advances in the structure and functions of
APA and in the design of ver); potent and selective inhibitors of this zin
c metallopeptidase. These compounds could have interesting applications in
the treatment of essential hypertension and their usefulness in cancer chem
otherapy warrants further investigations.